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Editorials
Coronary angioplasty of rapidly progressive
lesions — nothing to it or just too rare to be recognized
as a problem?
See page 1671 for the article to which this Editorial
refers
The paper from the Lille group in this issue''1 estab-
lishes a more than reasonable hypothesis only to
refute it on the basis of their well documented data
bank. They surmised that lesions having shown rapid
progression before angioplasty have a higher prepon-
derance for restenosis than those that built up more
slowly. This hypothesis is based on data of their own
group'21 and of others'31, revealing an increased rest-
enosis rate in patients undergoing coronary angio-
plasty for unstable angina. They carefully avoid
confusion with the high restenosis rate found after
angioplasty for rapidly recurring lesions reported
previously with data from the same data bank[4]. Such
lesions are of different structure and pathophysiology
(intimal proliferation and constructive remodelling)
whereas rapid progression of non-dilated lesions is
based on progressive atherosclerosis and plaque rup-
ture with organized thrombi'51. Much to their and my
surprise, the hypothesis fell short when scrutinized in
their prospectively accumulated and carefully main-
tained data bank. Did the authors find the truth or
did they fall victim to a type II error?
As often in biology, the answer is both 'yes'
and 'no' to both questions. One can deduct conclus-
ively from the paper that a rapidly progressive de
novo lesion that is dilated during an elective pro-
cedure yields results comparable with those of lesions
that have barely changed over the past 7 months.
However, these quiescent lesions that have progressed
recently but apparently have not been 'caught in the
act' are not the ones we are truly worried about. Our
concern in terms of acute problems and restenoses
focuses on truly unstable lesions. Even in the group
with rapid progression, only 20% of the patients
were considered as unstable. This is lower than
most series of unselected coronary angioplasty pro-
cedures. Two factors may account for the low per-
centage of unstable clinical presentations in a group
of patients with documented progression of their
coronary artery disease. First, the definition used
for unstable angina (chest pain with electrocardio-
graphic changes within 48 h before an elective
coronary angioplasty) is quite stringent and some-
what contradictory. Second, the series is explicitly
based on patients called in for a routine follow-up
angiography at about 6 months after an initial
successful coronary angioplasty. Through such a
narrow window, unstable angina is rare to see. The
authors then took a closer look at the patients with
unstable angina (i.e. nine people) but were unable to
confirm the high tendency of restenosis they had
described earlier121. This was a type II error trap if
ever there was one.
A number of additional points are of note in
the report. The average reference vessel diameter of
2-5 mm of a reasonably large cohort (85 patients) of
unselected coronary stenoses is small. This may be
intrinsic to the method of quantitative coronary an-
giography employed. It may or may not influence the
balloon selection. Again, the mean balloon diameter
of 2-8 mm is clearly below industry standards. A
certain systematic under-dilation cannot be excluded
and may account for the relatively high degree of
stenosis at the end of the procedure (32%) which, in
turn, lends to a high categorical percentage of rest-
enosis (not given in the paper) and a low late loss
(0-3 mm). A low mean late loss will reduce the power
of discrimination. A certain deficiency of the paper is
the absence of data concerning the acute outcome of
angioplasty in the two groups. The authors probably
wished to prevent false conclusions based on type I or
type II errors. In groups of only 40 patients, even in
stentless procedures as the ones described, acute
occlusion has only to be expected in about three
patients per group. Of course, if the rapidly pro-
gressing group had only included patients with truly
unstable angina, an increased incidence of acute
problems could have become apparent. With a
prevalence of unstable angina of 20% in the 'high
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risk' group and a mere 5% in the control group acute
events are likely to have been very rare.
It is easy to concur with the authors that
accidentally detected lesions that have recently
progressed can and should be dilated without a
significantly increased risk of recurrence. The
community of angioplasty operators is grateful for
these data, endorsing a long established practice.
However, the paper does not minimize the acute
problems or increased likelihood of restenosis
when it comes to plaques dilated at the very
moment of progression. The authors are far too
experienced not to have conveyed this caveat clearly
in the discussion.
B. MEIER
University Hospital,
Bern, Switzerland
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Arrhythmogenic right ventricular disease, dysplasia and
cardiomyopathy
See page 1717 for the article to which this Editorial
refers
This issue contains an interesting article on long-term
changes in the ECGs of patients with ventricular
arrhythmias originating in the right ventricle11'. The
authors describe their patients as having arrhyth-
mogenic right ventricular disease but quote exten-
sively references concerning arrhythmogenic right
ventricular dysplasia. In fact the term arrhyth-
mogenic right ventricular disease refers to a larger
group of patients than the classical arrhythmogenic
right ventricular dysplasia, which is clearly identified
by its specific histological structure rarely available in
a common clinical series12'.
In addition to the presence of ventricular
tachycardia (of unknown origin) the authors' criteria
for inclusion are based on contrast angiography. This
is also an interesting approach in clinical diagnosis
since angiography is strongly dependent on the
underlying anatomical structure and has generally
been considered as the 'gold standard' for the diagnosis
by showing evidence of segmental abnormalities'3'4'.
However, in addition to this approach the
authors have included in their selection the so-called
'more diffuse forms'. We are concerned that these
more diffuse forms may confuse the issue. Diffuse
dilatation of the right ventricle alone is not a sign
of arrhythmogenic right ventricular dysplasia. It
could be the result of different forms of idiopathic
cardiomyopathy mostly involving the right ventricle
without replacement of myocardial fibres by fatty
tissue'51. Even segmental abnormalities could be
the result of a localized form of healed myo-
carditis, ischaemia or cardiomyopathy16'. Only
specific segmental abnormalities, such as outpouching
bulges, microaneurysms, or deep fissures in the
infundibulum or at the apex are markers of arrhyth-
mogenic right ventricular dysplasia. However, such
comments are not of academic importance since the
prognosis of these various subgroups may be differ-
ent. For instance, the development of myocarditis
recently demonstrated in a subgroup of cases super-
imposed on arrhythmogenic right ventricular dys-
plasia could lead to progressive modification of the
ECG that is not the result of the dysplastic phenom-
enon (replacement of right ventricular musculature by
adipocytes and fibrous tissue) but a different phenom-
enon that could affect both right and left ventricles'71.
Therefore, the changes observed in some of the cases
may not be the result of evolution of the basic disease,
but the consequence of a different phenomenon acting
